Table 4.
Proportion of Cases and Costs Identified for the Different Screening Strategies for 75% Adherence to Initial Nonfasting Screening Strategies and 75% or 50% Adherence to 2-Hour OGTT
| Screening Strategy and Cutoff Value | 75% Adherence to Nonfasting Screening and 75% Adherence to 2-Hour OGTT
|
75% Adherence to Nonfasting Screening and 50% Adherence to 2-Hour OGTT
|
||||
|---|---|---|---|---|---|---|
| Cases Identified, % | Total Costs (Direct and Indirect), $ | Cost per Case Identified (Direct and Indirect), $ | Cases Identified, % | Total Costs (Direct and Indirect), $ | Cost per Case Identified (Direct and Indirect), $ | |
| Diabetes mellitus | ||||||
| 2-h OGTT (200 mg/dL) | 75 | 117 083 907 | 312 224 | 50 | 78 055 938 | 312 224 |
| HbAlc | ||||||
| 5.5% | 19 | 94 810 233 | 1011 410 | 12 | 86 053 541 | 1376994 |
| 5.7% | 19 | 85 855 882 | 915 888 | 12 | 80 083 973 | 1281472 |
| 6.5% | 19 | 70 931 963 | 756 683 | 12 | 70 134 694 | 1122 267 |
| Dysglycemia (prediabetes and diabetes) | ||||||
| 2-h OGTT (140 mg/dL) | 75 | 117083 907 | 390 | 50 | 78 055 938 | 390 |
| Random glucose test | ||||||
| 100 mg/dL | 31 | 74 820 378 | 605 | 21 | 67 551 971 | 819 |
| 110 mg/dL | 17 | 61 899 650 | 917 | 11 | 58 938 152 | 1310 |
| HbAlc | ||||||
| 5.5% | 25 | 94 405 496 | 932 | 17 | 85 783 716 | 1271 |
| 5.7% | 18 | 84 637 329 | 1176 | 12 | 79 271 605 | 1651 |
| 6.5% | 4 | 70 211 969 | 4458 | 3 | 69 654 698 | 6634 |
| 1-h Glucose challenge test | ||||||
| 110 mg/dL | 35 | 99 818 937 | 704 | 24 | 91 627 052 | 970 |
| 120 mg/dL | 25 | 88 976 034 | 899 | 17 | 84 398 450 | 1279 |
Abbreviations: HbA1c hemoglobin Alc; OGTT, oral glucose tolerance test.